Neuro-ophthalmology: Phase I trials

Safety Study of an Adeno-associated Virus Vector for Gene Therapy of Leber's Hereditary Optic Neuropathy (LHON)

Drug injection of scAAV2-P1ND4v2 5.00x10e9 vg (Low), Drug: injection of scAAV2-P1ND4v2 2.46X10e10 vg (Med) Drug: injection of scAAV2-P1ND4v2 1.0X10e11vg (High)

Phase I

United States

Recruiting

Click here for further information